Pharmacy
Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines
The FINANCIAL -- On the occasion of the World Health Assembly, the world’s research-based and generic & biosimilar pharmaceutical industry bodies...
Bayer submits marketing authorization applications for finerenone in the U.S. and the EU
The FINANCIAL -- Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the...
AstraZeneca’s Calquence approved in the EU for the treatment of most common type of leukaemia in adults
The FINANCIAL -- AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union...
FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke
The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability...
Astellas announced that China NMPA approved XTANDI for the treatment of prostate cancer
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National...
Roche to present new data across 16 blood disorders at the ASH 2020 Annual Meeting
The FINANCIAL -- Roche today announced that new data for its approved and investigational medicines will be presented at the...
EU approved AstraZeneca’s Forxiga for heart failure
The FINANCIAL -- AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure...
Bayer reported sales decrease by 5.1%
The FINANCIAL -- Bayer reported third quarter financial results. Highlights Group sales decrease by 5.1 percent (Fx & portfolio adj.)...
EU Commission approved Roche’s Tecentriq in combination with Avastin for the treatment of people with liver cancer
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in...
AstraZeneca to sell commercial rights to Atacand in more than 70 countries to Cheplapharm
The FINANCIAL -- AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil...
Novo Nordisk’s operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates
The FINANCIAL - Novo Nordisk published financial report for the period 1 January 2020 to 30 September 2020 Sales increased...
Bayer launches first Global Creative Council
The FINANCIAL -- Bayer launches its first Global Creative Council. This global initiative brings together senior leaders from a variety...
Lilly announced third-quarter earnings
The FINANCIAL -- Lilly reported Q3 financial results: - Revenue in the third quarter of 2020 increased 5 percent driven...
Gilead completed acquisition of Immunomedics
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) announced the completion of the previously announced transaction to acquire Immunomedics, Inc....
Bayer acquires AskBio for $4 bln
The FINANCIAL -- Bayer AG today announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in...
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
DXB wins Best Airport Award at AFLAS Awards
-
War in Ukraine Reshapes Georgia’s Real Estate Market Amid Shifting EU Ties
-
Trump of Russia: A Web of Business, Politics, and Alleged Espionage
-
LDN: The Anti-Inflammatory and Longevity Potential of Low Dose Naltrexone
-
Who Is the Owner of QI Company? A Look at the QI Group’s Leadership Shaping Its Future
-
Elon Musk’s Influence on Donald Trump: A Pathway to Wealth and Power
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
